Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicity
Kate R. Secombe, Janet K. Coller, Rachel J. Gibson, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 10, pp. 2365-2376
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

The Microbiota-Gut-Brain Axis
John F. Cryan, Kenneth J. O’Riordan, Caitlin S.M. Cowan, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1877-2013
Open Access | Times Cited: 3470
The microbiome and gynaecological cancer development, prevention and therapy
Paweł Łaniewski, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 232-250
Open Access | Times Cited: 301
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
Winnie M. C. van den Boogaard, Daphne S. J. Komninos, Wilbert P. Vermeij
Cancers (2022) Vol. 14, Iss. 3, pp. 627-627
Open Access | Times Cited: 261
Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism
Ifeoma Julieth Dikeocha, Abdelkodose Mohammed Al‐Kabsi, Muhammad Miftahussurur, et al.
The FASEB Journal (2022) Vol. 36, Iss. 6
Open Access | Times Cited: 49
Astragalus polysaccharides attenuate chemotherapy-induced immune injury by modulating gut microbiota and polyunsaturated fatty acid metabolism
Hao Wang, Weize Zhu, Ying Hong, et al.
Phytomedicine (2024) Vol. 128, pp. 155492-155492
Closed Access | Times Cited: 16
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer
Jie Shen, Hao Sun, Jing Chu, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes
Sara Fanijavadi, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 730-730
Open Access | Times Cited: 1
Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
Hannah R. Wardill, Kate R. Secombe, Robert V. Bryant, et al.
EBioMedicine (2019) Vol. 44, pp. 730-740
Open Access | Times Cited: 63
Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome
Kate R. Secombe, Ysabella Van Sebille, Bronwen J. Mayo, et al.
Integrative Cancer Therapies (2020) Vol. 19
Open Access | Times Cited: 58
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4824-4824
Open Access | Times Cited: 48
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Wenyu Li, Xiaorong Deng, Tingtao Chen
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
Role of the microbiome in oral cancer occurrence, progression and therapy
Zhengrui Li, Yuan Liu, Ling Zhang
Microbial Pathogenesis (2022) Vol. 169, pp. 105638-105638
Closed Access | Times Cited: 36
Mobile Health Application-Based Interventions to Improve Self-management of Chemotherapy-Related Symptoms Among People with Breast Cancer Who Are Undergoing Chemotherapy: A Systematic Review
Nuo Shi, Arkers Kwan Ching Wong, Frances Kam Yuet Wong, et al.
The Oncologist (2023) Vol. 28, Iss. 4, pp. e175-e182
Open Access | Times Cited: 20
Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management
Yunjing He, Jingrui Zheng, Binbin Ye, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115787-115787
Closed Access | Times Cited: 19
The role of gut microbiota and metabolites in cancer chemotherapy
Shiyu Li, Shuangli Zhu, Jun Yu
Journal of Advanced Research (2023) Vol. 64, pp. 223-235
Open Access | Times Cited: 19
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 41
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
Byeongsang Oh, Frances Boyle, Nick Pavlakis, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis
Ghanyah Al-Qadami, Ysabella Van Sebille, Joanne M. Bowen, et al.
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 28
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
Romy Aarnoutse, Janine Ziemons, Lars E. Hillege, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 28
The Future of Microbiome‐Based Therapeutics in Clinical Applications
Anukriti Sharma, Promi Das, Mary M. Buschmann, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 107, Iss. 1, pp. 123-128
Closed Access | Times Cited: 42
The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy
Min Zhang, Huan Zhou, Shanshan Xu, et al.
Annals of Palliative Medicine (2020) Vol. 9, Iss. 6, pp. 4211-4227
Open Access | Times Cited: 37
Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo
Hui Zhu, Chun‐Yi Lu, Fei Gao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112192-112192
Open Access | Times Cited: 32
BDE-209-induced genotoxicity, intestinal damage and intestinal microbiota dysbiosis in zebrafish (Danio Rerio)
Jing Wang, Chen Liu, Shuping Wang, et al.
The Science of The Total Environment (2023) Vol. 905, pp. 167009-167009
Closed Access | Times Cited: 13
One immune system plays many parts: The dynamic role of the immune system in chronic pain and opioid pharmacology
Sanam Mustafa, Juliana E. Bajic, Benjamin Barry, et al.
Neuropharmacology (2023) Vol. 228, pp. 109459-109459
Open Access | Times Cited: 12
Gut microbiota resilience and recovery after anticancer chemotherapy
Sara Roggiani, Mariachiara Mengoli, Gabriele Conti, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 16-16
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top